Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 Sep 9;44(20-22):e70184. doi: 10.1002/sim.70184

Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf‐Life Estimation

Lingjiao Wang 1, Yang Han 1,, Wei Liu 2, Frank Bretz 3,4
PMCID: PMC12418920  PMID: 40923696

ABSTRACT

One important property of any drug product is its stability over time. A key objective in drug stability studies is to estimate the shelf‐life of a drug, involving a suitable definition of the true shelf‐life and the construction of an appropriate estimate of the true shelf‐life. Simultaneous confidence bands (SCBs) for percentiles in linear regression are valuable tools for determining the shelf‐life in drug stability studies. In this paper, we propose a novel criterion, the Minimum Area Confidence Set (MACS) criterion, for finding the optimal SCB for percentile regression lines. This criterion focuses on the area of the constrained regions for the newly proposed pivotal quantities, which are generated from the confidence set for the unknown parameters of an SCB. We employ the new pivotal quantities to construct exact SCBs over any finite covariate intervals and use the MACS criterion to compare several SCBs of different forms. The optimal SCB under the MACS criterion can be used to construct the interval estimate of the true shelf‐life. Furthermore, a new computationally efficient method is proposed for calculating the critical constants of exact SCBs for percentile regression lines. A real data example on drug stability is provided for illustration.

Keywords: confidence set, drug stability study, multiple testing, percentile line, shelf‐life, simultaneous confidence band

1. Introduction

In drug development, a key property of any drug product is its stability over time. Drug stability studies are routinely conducted in order to measure the degradation of new drug products or existing drugs that have been reformulated or repackaged, as outlined by International Council of Harmonasation (ICH) guideline on stability testing of new drug substances and products; see ICH [1]. These studies provide patients and consumers with a high degree of confidence that a drug retains its strength, quality, and purity under appropriate storage conditions. Individual dosage units (e.g., tablets, capsules, vials) are sampled at predetermined time points and assayed for their active pharmaceutical ingredient (drug) content. The decline in drug content over time can be modeled based on these observations.

One important objective in drug stability studies is to estimate the true shelf‐life of a drug. The estimated shelf‐life is the storage period during which the potency of a drug product is expected to remain within the approved specification limit with an acceptable probability. The final day of the shelf life is known as the expiry date, which is required to be printed on the package label of the corresponding drug. According to ICH [2], the approved specification limits are no greater than ±10% of the labeled content of the drug. Current ICH guidelines, adopted by the U.S. Food and Drug Administration (FDA) and other major national regulatory agencies, recommend that the shelf‐life estimate should be based on an interval estimate of the mean change in drug content over storage time. Specifically, as outlined in ICH [1], the interval estimate of shelf‐life for a single batch is defined as the time interval during which the 1α=95% confidence interval for the mean regression line of the observed drug content (y) and the time (x) crosses a pre‐specified level h of drug content, say h=98 (in percentage).

A commonly used statistical model for this purpose is simple linear regression of drug content (y) on the covariate time (x); see Kiermeier et al. [3], Quinlan et al. [4], and Liu et al. [5] for a review. Throughout this paper, we focus on linear regression for a single batch of drug, assuming that the drug content decreases over time, which results in a negative slope for the regression line. The situation where the drug content increases over time can be treated using a similar approach. To be specific, let the statistical model be y=xTβ+ϵ=β0+β1x+ϵ, where y denotes the observed drug content at time point x of the dosage unit, x=(1,x)T, β=(β0,β1)T, the random error ϵ follows a normal distribution N(0,σ2), and β0, β1 and σ2 are unknown parameters.

One problem in estimating the shelf‐life is deciding whether to construct a confidence interval for the average content of all dosage units, xTβ, or for the content of a γ proportion of all dosage units, xTβ+zγσ, with zγ denoting the 100γth percentile of standard normal distribution; see Ruberg and Stegeman [6]. According to the interval estimates of batch shelf‐life defined by ICH [1], the estimation is based on a (1α)‐level confidence interval for the mean regression line, which implies that only half (i.e., 50%) of all the individual dosage units of the drug should have a drug content of at least h by the shelf‐life. However, from the patients' and consumers' point of view, it is expected that a larger proportion (e.g., 90%) of all the individual dosage units will have a drug content above the acceptable limit h by the expiry date. Quinlan et al. [4] also note that the ICH method can overestimate the true shelf‐life, making it inappropriate for ensuring drug safety.

Kiermeier et al. [3] consider an approximate (1α)‐level pointwise confidence band (PCB) for the 100γth percentile regression line to provide an accurate estimate of the true shelf‐life. This PCB offers the inference of drug content for 100(1γ)% of dose units at one specific time point. Liu et al. [5] provide a new method to address this problem by determining the shelf‐life using an exact (1α)‐level PCB for the percentile line in linear regression.

Note that, the true shelf‐life can occur at any time point during the drug stability study period. Therefore, using simultaneous confidence bands (SCBs) to estimate the shelf‐life is a suitable approach, as the SCBs guarantee the confidence level 1α of estimation at any time point within the covariate range of interest. SCBs for percentiles in linear regression are studied by Steinhorst and Bowden [7], Turner and Bowden [8, 9], and Thomas and Thomas [10] over the whole covariate range (,). As the expiry date required by the regulatory to be printed on the package label of a drug often has a limit, it is reasonable to consider a finite interval of shelf‐life, that is, x(a,b). The specific duration of the expiration date varies depending on the drug product, its formulation, and stability testing results, but often a=0 and b=2 (in years) to justify an expiration dating period of over two years. Han et al. [11] construct exact SCBs over a finite covariate interval (a,b) and develop asymmetric SCBs for the 100γth percentile line, which could be used for more informative interval estimates of shelf‐life than the SCBs over (,).

Han et al. [11] is the only available method for constructing exact symmetric and asymmetric SCBs. However, the pivotal quantities used in their approach for different types of SCBs vary in dimension, which complicates the implementation of their methods. In addition, they propose two methods for calculating the critical constants of SCBs: a simulation‐based method and a numerical quadrature method, both of which are computationally intensive.

As reviewed in Table 1, there are various forms of SCBs available in the statistical literature, and so it is desirable to identify the most informative SCB among different forms under a suitable criterion. Han et al. [11] determine the optimal SCB under the average width (AW) criterion [12]. The AW of a SCB is the average width between its upper and lower bounds over the covariate interval of interest (a,b), and has been widely used as an optimality criterion for comparing different forms of confidence bands; see Liu et al. [13]. It is noteworthy that the AW criterion has one limitation that it cannot directly provide the information of the unknown parameters β and σ when both parameters are of primary interest. Liu and Hayter [14] introduce the minimum area confidence set (MACS) criterion based on the area of the confidence set for β only, focusing on the SCBs for the mean regression line xTβ, see also Liu et al. [15] and Liu and Ah‐kine [16]. However, when estimating the shelf‐life, the SCBs for percentile lines are required, rather than the mean regression line, in order to assess whether a large proportion of dose units have a drug content above the threshold. In addition, note that making simultaneous inference for a percentile regression line over x(a,b) is equivalent to constructing the joint confidence set for β and σ. Therefore, this paper considers the MACS criterion based on the area of the confidence set for the unknown parameters β and σ. To date, no work in the literature has addressed such a MACS criterion for constructing and comparing SCBs for a percentile regression line.

TABLE 1.

Six simultaneous confidence bands.

Name Type
ξ1
ξ2
Origin
SB
I
1 0 Steinhorst and Bowden [7]
TBU
I
2νΓ(ν+12)Γ(ν2)
0 Turner and Bowden [8]
TBE
I
2νΓ(ν2)Γ(ν12)
0 Turner and Bowden [8]
V
II
1
12νΓ(ν+12)Γ(ν2)2
Han et al. [11]
UV
II
2νΓ(ν+12)Γ(ν2)
ν2Γ(ν2)Γ(ν+12)21
Han et al. [11]
TT
II
4ν14ν
12ν
Thomas and Thomas [10]

In the following, we construct exact (1α)‐level symmetric and asymmetric two‐sided SCBs for the 100γth percentile line over any given covariate interval (a,b) to provide accurate interval estimates of shelf‐life. Note that both the lower and upper bounds are important for the patients, consumers, and manufacturers. Specifically, the lower bound of the interval estimate of the shelf‐life, based on the two‐sided SCBs, indicates that at least a (1γ) proportion of all dosage units maintain a drug content above the limit h by this time point. The corresponding upper bound of the interval estimate of the shelf‐life represents the time point beyond which less than (1γ) proportion of all dosage units retain a drug content above h. Hence, the two‐sided SCBs of our method can be applied to produce both upper or lower bounds for shelf‐life.

This paper makes three main contributions. First, we construct new pivotal quantities for the exact two‐sided (1α)‐SCBs for the 100γth percentile line, xTβ+zγσ, over any given covariate interval x(a,b). Our newly proposed pivotal quantities link SCBs to the confidence set for the unknown parameters (β,σ) in linear regression. Furthermore, these pivotal quantities provide a more general approach for developing SCBs, making them applicable to all SCB types. Second, we develop the new MACS criterion to determine optimal SCBs that minimize the area of the confidence set for the unknown parameters (β,σ) by minimizing the area of the constrained regions for our new pivotal quantities. Third, we provide an efficient and exact method to compute the critical constants of SCBs for percentile lines. This new method uses numerical quadrature based on the newly proposed pivotal quantities. In comparison with the methods of Han et al. [11], it not only reduces the dimensions of the numerical integration but also eliminates the need for simulations, resulting in a significant reduction in computational costs.

Accordingly, this paper is organized as follows. In Section 2, we provide the details of the newly proposed pivotal quantities for the exact SCBs for percentile lines and the construction of the MACS criterion, including the numerical computation of the critical constants in Section 2.4. In Section 3, we report the results of a simulation study to assess the performances of different forms of SCBs, both symmetric and asymmetric, under the MACS criterion. In Section 4, we illustrate the proposed method with an illustrative example to determine the shelf‐life of a drug by using SCBs for percentile lines. Finally, Section 5 contains conclusions and discussions. The computational costs of our newly proposed method and the previous simulation‐based method, along with additional simulation results, are provided in the Supporting Information to save space.

2. Methodology

In this section, we focus on the construction of the MACS criterion for the exact (1α)‐level SCBs for the 100γth percentile line over any pre‐specified interval of interest x(a,b).

2.1. Preliminaries

Consider the simple linear regression model

y=xTβ+ϵ=β0+β1x+ϵ (1)

where x=(1,x)T, β=(β0,β1)T, and the random error ϵ is assumed to follow a normal distribution N(0,σ2). For a given dataset ={(xi,yi),i=1,,n}, let X denote the n×2 design matrix, the ith row of which is given by xi=(1,xi), i=1,2,,n. Denote the least squares estimator of β and the unbiased estimator of σ2 by β^=(β^0,β^1)T=(XTX)1XTy and σ^2=yXβ^2/ν with ν=n2 and y=(y1,,yn)T. Then, we have β^N2(β,σ2(XTX)1), σ^/σχν2/ν with the degrees of freedom ν, and β^ and σ^ are independent random variables. To facilitate the computation of critical constants in Section 2.2, we consider the mean‐centered design matrix without loss of generality.

In this paper, the true shelf‐life is defined as the time point Xγ, based on the 100γth percentile line xTβ+zγσ, that satisfies

β0+β1Xγ+zγσ=h

where zγ is the 100γth percentile of the standard normal distribution, and h is the pre‐specified acceptable limit of the drug content level. Hence, by the time point Xγ, no more than 100γ% (with γ=0.05) of all the individual dosage units will have a drug content below the acceptable limit h. It is noteworthy that the mean regression line xTβ is the 50th percentile line, which is a special case of xTβ+zγσ with γ=0.5.

The definition of the SCBs [l(x),u(x)], for the 100γth percentile line xTβ+zγσ, is given as follows.

Definition 1

A confidence band [l(x),u(x)], which satisfies

inf<β0,β1<,σ>0Pl(x)xTβ+zγσu(x)for allx(a,b)=1α (2)

is called a (1α)‐level simultaneous confidence band for the 100γth percentile line xTβ+zγσ, over a finite interval of interest x(a,b).

Consider two‐sided SCBs of the form

xTβ^+zγσ^ξ1c1σ^xT(XTX)1x+(zγ)2ξ2xTβ+zγσxTβ^+zγσ^ξ1+c2σ^xT(XTX)1x+(zγ)2ξ2for allx(a,b) (3)

where c1 and c2 are the critical constants that satisfy (2), and the constants ξ10 and ξ2 are given and selected for constructing different forms of SCBs. The SCBs of the form (3) can be divided into symmetric and asymmetric based on whether c1=c2 or c1c2, respectively, and into Type I and Type II based on whether ξ2=0 or ξ20, respectively. For upper one‐sided SCBs, we have c1=, and for lower one‐sided SCBs, we have c2=.

Six different forms of SCBs have been published in the literature, with various (ξ1,ξ2)‐values. Table 1 gives the values of ξ1 and ξ2 for these six bands: SB, TBU, TBE (Type I with ξ2=0), V, UV and TT (Type II with ξ20). The corresponding asymmetric bands are denoted as SBa, TBUa, TBEa, Va, UVa, and TTa.

Han et al. [11] provide a two‐dimensional pivotal quantity for constructing the Type I band and a three‐dimensional pivotal quantity for constructing the Type II band. In this section, we construct a more general pivotal quantity that can be applied to both Type I and Type II bands in Table 1. All these six forms in Table 1 are compared under the MACS criterion in Section 3.

2.2. Pivotal Quantities and Confidence Sets

In this section, we construct the new pivotal quantities to provide a general way for developing the SCBs in Table 1, regardless of their types. The constrained regions for the new pivotal quantities and the confidence sets for unknown parameters (β0,β1,σ) are also provided based on the corresponding SCBs.

Without loss of generality, we use the mean‐centered covariate values to fit the regression in (1). Then, the covariate x in (1) is replaced by (xx), where x=1ni=1nxi denotes the mean of xi‐values in the training dataset ={(xi,yi),i=1,,n}. Accordingly, the vector x in (1) becomes x=(1,xx)T, and the ith row of design matrix X becomes (1,xix). Let Sxx=i=1n(xix)2, then (XTX)1=1/n001/Sxx is a 2×2 diagonal matrix. Let P be the square root matrix of (XTX)1 given by

P=(XTX)1/2=1n001Sxx

and Px=(1n,xxSxx)T. From (3), the confidence level of a two‐sided SCB is given by

PxTβ^+zγσ^ξ1c1σ^xT(XTX)1x+(zγ)2ξ2xTβ+zγσxTβ^+zγσ^ξ1+c2σ^xT(XTX)1x+(zγ)2ξ2for allx(a,b)=Pc2(Px)TNU+zγ(1ξ11U)(Px)T(Px)+(zγ)2ξ2c1for allx(a,b)=Pc2N1n+N2(xx)SxxU+zγ(1ξ11U)1n+(xx)2Sxx+zγ2ξ2c1forallx(a,b) (4)

where N:=(N1,N2)T=P1(β^β)/σN2(0,I2), and U:=σ^/σχν2/ν.

Let w=1n+zγ2ξ2,xxSxxT. Define the new pivotal quantity

K=K1K2=N1zγnU1+nzγ2ξ2+zγnξ11+nzγ2ξ2N2/U (5)

and a region of K, denoted as RK, by

RK=K:c2wTKwc1for allx(a,b)2. (6)

Then, in general, the critical constants (c1,c2) for all (1α)‐level SCBs in Table 1 satisfy that P{KRK}=1α.

Next, we develop the confidence sets for unknown parameters θ=(β0,β1,σ)T using the region RK in (6). Let a=zγnξ11+nzγ2ξ2,0T, b=(β^0,β^1,0)T, M=11+nzγ2ξ2001 and U=1σ^n0zγn0Sxx0. Then the confidence set for unknown parameters θ=(β0,β1,σ)T is given by

Cθ=θ:KRK=θ:MU(bθ)+aRK3; (7)

the detailed derivation is provided in Appendix A. The new criterion is based on the area of the confidence set Cθ for θ. The smaller the area of Cθ, the better and more informative the corresponding SCB. Intuitively, each θ in a confidence set corresponds to one 100γth percentile line xTβ+zγσ that lies completely inside the corresponding SCB and vice versa. Note that the pivotal quantity K is generated from the parameter θ via the transformation K=MU(bθ)+a. It is clear that the distribution of K depends on the values of (ξ1,ξ2) via the shift a and scaling M. Consequently, when comparing the SCBs in Table 1 with various (ξ1,ξ2)‐values, one cannot conclude that a smaller area of RK necessarily implies a smaller confidence set Cθ for unknown parameter θ.

Next, we develop a new pivotal quantity, defined as T=U(bθ)=N1zγnU,N2UT, which does not depend on the values of (ξ1,ξ2). Also, we define the region RT by

RT=T:MT+aRK=T:TM1RKM1a2.

Then, the confidence set Cθ in (7) can further be represented as

Cθ=θ:MT+aRK={θ:TRT}3.

Since the transformation T=U(bθ) is independent of (ξ1,ξ2)‐values, then a smaller area of RT corresponds to a smaller confidence set Cθ for unknown parameter θ. Hence, we measure the volume of the confidence set Cθ in terms of the area of RT, which is given in the theorem below.

Theorem 1

The area of RT is given in terms of the area of RK by

Area(RT)=|M1|Area(RK)=Area(RK)1+nzγ2ξ2 (8)

where Area(C) denotes the area of set C.

By using matrix scaling and geometric scaling, we have

Area(RT)=|M1|Area(RK)=Area(RK)11+nzγ2ξ20011=Area(RK)1+nzγ2ξ2.

2.3. MACS Criterion

In this section, we propose and discuss the new optimality criterion, the MACS criterion, based on our newly introduced pivotal quantities K and T.

Criterion: For given values of γ, n, the design matrix X and the covariate interval of interest (a,b) in (3), the optimal (1α)‐level SCB has the smallest Area(RT) in (8) among all possible regions satisfying P{KRK}=1α.

In order to determine the optimal SCB among all possible forms given in Table 1, the area of RT, Area(RT), for each SCB should be computed and compared. Since Area(RT) depends on Area(RK), as shown in Theorem 1, we next focus on deriving Area(RK) using the polar coordinates of the pivotal quantity K.

The constraints in (6) restrict K to the lemon‐shaped region RK in Figure 1c, bounded by two thick curved lines K:wTKwc1for allx(a,b) given in Figure 1a and K:c2wTKwfor allx(a,b) given in Figure 1b. The angle ϕ=ϕ1+ϕ2 is formed by the boundary vectors of w over x(a,b), where the boundary vectors are given by wa=1n+zγ2ξ2,axSxxT and wb=1n+zγ2ξ2,bxSxxT. Then, ϕ is calculated from

cos(ϕ)=1n+zγ2ξ2+(ax)(bx)Sxx1n+zγ2ξ2+(ax)2Sxx1n+zγ2ξ2+(bx)2Sxx. (9)

In Figure 1, ϕ(0,π) increases when (ba) increases, and the critical constants c1 and c2 can be determined from the equation P{KRK}=1α. Note that the set RK in Figure 1c is partitioned into four triangles RK;Mi and four fans RK;Oi (i=1,2,3,4); see Figure 1d. Thus, the set RK can be expressed as

RK=i=14RK;MiRK;Oi.

Based on this expression of RK, we can simplify the calculation of the confidence level P{KRK} for SCBs in Table 1 by using the polar coordinates of K as shown next.

FIGURE 1.

FIGURE 1

(a–c) The construction of RK; (d) The partitioned regions of RK. (a) The right boundary of RK, denoted by K:wTKwc1for allx(a,b). (b) The left boundary of RK, denoted by K:c2wTKwfor allx(a,b). (c) The area of RK, denoted by K:c2wTKwc1for allx(a,b). (d) The partitioned regions of RK by using polar coordinates of K.

Let (R,δ) be the polar coordinates of K=(K1,K2)T, i.e., K1=Rcosδ and K2=Rsinδ, where R=K>0 and δ[0,2π) is the angle between the vectors (1,0)T and K. The joint density of (R,δ) is given by

fR,δ(r,δ)=fK1,K2(k1,k2)r=rexp(q32/2)νν/2q12ν/2πΓ(ν/2)0k3ν+1×exp12rcosδq2q12+r2(sinδ)2+νk32+2q3(rcosδq2)q1k3dk3 (10)

where ν=n2, q1=11+nzγ2ξ2, q2=zγnξ11+nzγ2ξ2 and q3=zγn; the derivation of fK1,K2(k1,k2) in (10) is given in Appendix C.

The theorem below gives an expression of the confidence level of an SCB using (10) and Figure 1d.

Theorem 2

For given c1 and c2, the confidence level of the SCB can be expressed as:

PxTβ^+zγσ^ξ1c1σ^xT(XTX)1x+(zγ)2ξ2xTβ+zγσxTβ^+zγσ^ξ1+c2σ^xT(XTX)1x+(zγ)2ξ2for allx(a,b)=P{KRK}=P(R,δ)i=14RK;MiRK;Oi=i=14P(R,δ)RK;Mi+P(R,δ)RK;Oi=i=14(R,δ)RK;MifR,δ(r,δ)drdδ+(R,δ)RK;OifR,δ(r,δ)drdδ.

The proof of Theorem 2 is given in Appendix D. From Theorems 1 and 2, for a given type of SCBs in (3) with given (ξ1, ξ2), γ, design matrix X and covariate interval (a,b), the critical constants (c1,c2) of the optimal SCB under the MACS criterion can be determined by minimizing the Area(RT) in (8) subject to the constraint P{KRK}=1α.

2.4. Computation of the Critical Constants c1 and c2

In this section, we provide a general algorithm for computing the critical constants (c1,c2) using the polar coordinates (R,δ) of pivotal quantity K and Theorem 2. For a symmetric SCB with c1=c2=c, determining the critical constant c can be simplified to a root‐finding problem, that is, computing the unique root c that satisfies P{KRK}|c1=c2=c=1α according to Theorem 2. Note that a symmetric SCB is just a special case of the SCB in (3). Hence, the critical constant c for the symmetric SCB can be used as the starting point for searching the critical constants (c1,c2) of the corresponding optimal MACS asymmetric SCB with c1c2. It is noteworthy that if γ0.5 then c1c, and if γ0.5 then c2c. We use Algorithm 1 for computing the (c1,c2) of the optimal MACS asymmetric SCBs.

ALGORITHM 1. Compute the (c1,c2) of the optimal MACS asymmetric SCB.

ALGORITHM 1

Han et al. [11] compare the SCBs in Table 1 under the AW criterion. For given values of γ, n, the design matrix X and the covariate interval of interest (a,b) in (3), the optimal (1α)‐level SCB has the smallest AW, where

AW=1baab(c1+c2)σ^xT(XTX)1x+(zγ)2ξ2dx. (11)

Han et al. [11] propose two methods for computing the critical constants (c1,c2): a numerical quadrature method and a simulation‐based method. Next, we illustrate how the computational methods in Han et al. [11] are more time‐consuming than the method of this paper in Algorithm 1.

For the numerical quadrature method of Han et al. [11], the critical constants are computed exactly by solving equations that involve three‐dimensional integrations and indicator functions, given by

0f(n1,n2,u)Ic2N1n+N2(xx)SxxU+zγ(1ξ11U)1n+(xx)2Sxx+zγ2ξ2c1for allx(a,b)dn1dn2du=1α

where f(n1,n2,u) is the joint density function of (N1,N2,U), and IA denotes the indicator function of the set A. Due to the three‐dimensional numerical quadrature involved, it takes substantially longer computation time than the method of this paper, which uses only two‐dimensional numerical quadrature.

For the simulation‐based method of Han et al. [11], they first generate L independent replicates of (N,U): (Ni,Ui) for i=1,,L, and then compute the corresponding (c1;i,c2;i)‐values. Finally, the pair (c1,c2) for an asymmetric SCB is selected such that it not only satisfies the confidence level 1α but also minimizes the AW in (11). The computational costs are reduced considerably by using this simulation‐based method in comparison with their numerical quadrature method. However, L=1000000 iterations are required to ensure the critical constants are accurate to at least two decimal places.

In contrast, the new method does not involve a Monte Carlo simulation and takes only a few seconds to compute the critical constants. This enables the dynamic construction of SCBs to be performed efficiently.

To highlight the improvements in computational efficiency, we conducted a simulation study to compare our new method with the simulation‐based approach. Since the numerical quadrature method is even more time‐consuming than the simulation‐based method, we do not compare our new method with the numerical quadrature method in this simulation study. Our numerical results show that the computation of critical constants using our newly proposed method takes about 20 s for symmetric SCBs and about 200 s for asymmetric SCBs on an ordinary Windows PC (Intel(R) Core(TM) i7‐6700 CPU with 3.40 GHz, 3.41 GHz, RAM 16.0 GB). In contrast, the simulation‐based method in Han et al. [11] takes over 8×102 s for symmetric SCBs and no less than 4×103 s for asymmetric SCBs on the same Windows PC, using 1 000 000 simulations. This decrease in time by about one magnitude demonstrates that our newly proposed method is significantly more efficient. Detailed computational costs for various scenarios are provided in the Supporting Information.

3. Simulation Study for Evaluating the Performance of SCBs

In our numerical comparisons, we assess the performance of symmetric and asymmetric SCBs within each type (Type I bands with ξ2=0 and Type II bands with ξ20), as well as compare the performance across Type I and Type II bands, in various scenarios.

3.1. Design of Simulation Study

Note that the critical constants (c1,c2) for SCBs and the areas of regions RK in (6) depend on the design matrix X, the interval (a,b), n, γ, and 1α. Based on this, we design the simulation study as follows. Given the data ={(xi,yi),i=1,,n}, we have the mean x=1ni=1nxi and the sum of squares Sxx=i=1n(xix)2. Here, we focus on the case where ax=(bx), i.e., the interval x(a,b) is symmetric around x. Let s=bxSxx=axSxx. Recall w=1n+zγ2ξ2,xxSxxT in (6). The Area(RK) then depends on the value of xxSxx, which lies in the interval axSxx,bxSxx=(s,s) and is symmetric about 0. Note that s=ba2Sxx, then the value of (ba) increases as s increases. Thus, the critical constants (c1,c2) depend on the design matrix X and the covariate interval (a,b) via s. In this case, the critical constants (c1,c2) and the areas of regions RK depend only on s, n, γ, and 1α.

In total, 12 different exact SCBs are considered under 24 different scenarios. The 12 SCBs include both the symmetric and asymmetric bands of the six forms given in Table 1. The 24 scenarios are derived from different combinations of the confidence level 1α, percentile γ, sample size n, and value of s. In our numerical comparison, the settings we used are as follows: (i) confidence level: 1α=0.90,0.99; (ii) percentile: γ=0.75,0.95; (iii) sample size: n=10,100; and (iv) s=0.1,1,10.

3.2. Measuring Performance of SCBs

The main goal of the simulation study is to identify the optimal form of SCBs under the MACS criterion. To make the evaluation more concrete and quantifiable, we assess the performance of different SCBs by comparing the ratios of areas of the regions RT.

Suppose two bands A and B have regions RT;A and RT;B, respectively, for given values of (a,b), n, α, γ, ξ1 and ξ2. Clearly the ratio

r=Area(RT;B)Area(RT;A) (12)

is of interest for comparing bands A and B under the MACS criterion. When r>1, the area of RT;A is smaller and the corresponding confidence set for unknown parameter θ is smaller, and so A is better than B; otherwise, B is better than A.

3.3. Simulation Results

The results of the simulation study are summarized here using the r‐ratio in (12). According to (9), the ϕ‐values for each SCB depend on (a,b) and X only through s. For Type I bands, the ϕ‐values are the same because ξ2 is fixed at ξ2=0. However, for Type II bands, the ϕ‐values depend on different ξ2‐values. Even with different ξ2‐values, the ϕ‐values for all Type II bands remain the same up to two decimal places for given s and n. In Table 2, ϕI and ϕII denote the ϕ‐values for Type I and Type II bands, respectively.

TABLE 2.

Ratios r, relative to UVa, of Area(RT) for SCBs: TBE, TBEa, UV.

1α
γ
n
s
ϕI
ϕII
TBE TBEa UV UVa
0.90 0.75 10 0.1 0.613 0.543 1.003 1.003 1.020 1
      1 2.529 2.451 1.007 1.004 1.023 1
      10 3.078 3.070 1.003 0.998 1.020 1
    100 0.1 1.571 1.466 1.012 1.010 1.001 1
      1 2.942 2.920 1.006 1.006 1.001 1
      10 3.122 3.119 1.006 1.006 1.001 1
  0.95 10 0.1 0.613 0.543 1.014 1.013 1.081 1
      1 2.529 2.451 1.124 1.118 1.090 1
      10 3.078 3.070 1.098 1.084 1.071 1
    100 0.1 1.571 1.466 1.087 1.087 1.003 1
      1 2.942 2.920 1.112 1.111 1.003 1
      10 3.122 3.119 1.112 1.107 1.003 1
0.99 0.75 10 0.1 0.613 0.543 1.211 1.004 1.286 1
      1 2.529 2.451 1.155 0.992 1.172 1
      10 3.078 3.070 1.126 0.968 1.143 1
    100 0.1 1.571 1.466 1.033 1.019 1.021 1
      1 2.942 2.920 1.023 1.007 1.015 1
      10 3.122 3.119 1.022 1.005 1.015 1
  0.95 10 0.1 0.613 0.543 1.581 1.017 1.731 1
      1 2.529 2.451 1.770 1.056 1.464 1
      10 3.078 3.070 1.618 0.906 1.317 1
    100 0.1 1.571 1.466 1.197 1.144 1.070 1
      1 2.942 2.920 1.267 1.179 1.046 1
      10 3.122 3.119 1.264 1.162 1.044 1

Note: ϕI is the angle ϕ in (9) for Type I bands with ξ2=0 (TBE and TBEa). ϕII is the angle ϕ in (9) for Type II bands with ξ20 (UV and UVa).

Based on our numerical results within each type, asymmetric SCBs have smaller areas of RT and are better than symmetric SCBs, for both Type I and Type II bands. For Type I bands, asymmetric SCBs (SBa, TBUa, TBEa) outperform symmetric SCBs (SB, TBU, TBE) by up to about 100% when both 1α and γ are large. Among the three symmetric Type I bands, TBE has the smallest area of RT, and so TBE is the best in terms of MACS. The difference in the areas of RT among the three asymmetric Type I bands is small. For Type II bands, asymmetric SCBs (Va, TTa, UVa) are better than symmetric SCBs (V, TT, UV), by as much as about 80% when 1α is large and s is small. Among the three symmetric Type II bands, the V band consistently performs slightly worse than the UV band under the MACS criterion, and therefore, the V band is not recommended. The differences in the areas of RT between UV and TT are small, so either band can be used. Additionally, the differences in the areas of RT among the three asymmetric Type II bands are small. In general, an asymmetric SCB is better than the corresponding symmetric SCB according to the MACS criterion. The detailed numerical results are provided in the Supporting Information.

In the comparative analysis across Type I and Type II bands, we focus on the performance of the TBE, TBEa, UV, and UVa bands under the MACS criterion, as TBE and UV are the best Type I band and Type II band, respectively. Table 2 presents the r‐ratios of Area(RT) for TBE, TBEa, and UV relative to UVa. Note that the r‐ratios for symmetric bands are always larger than one, indicating that the asymmetric bands (TBEa and UVa) outperform the symmetric bands (TBE and UV). When n=100, UVa is the best, with the Area(RT) for UVa consistently smaller than that for TBEa. When n=10, UVa is the best in most cases, while TBEa performs best if the x‐values in the training dataset are dispersed (i.e., n=10 and s=10).

Based on the results in Table 2, we conduct a comparison between TBEa and UVa in Figure 2 with n=10, γ=0.75,0.95 and 1α=0.90,0.99. The ϕI‐values for Type I bands are utilized as ϕ‐axis. Figure 2 reveal that the r‐ratio is below 1 for large ϕ and 1α (e.g., ϕ>2.8 and 1α=0.99). Therefore, we can conclude that TBEa is better than UVa when both ϕ and 1α are large, and n is small. It is also noteworthy that ϕI and ϕII are larger than 3 when s10, indicating that the x‐values of the training dataset are dispersed. Hence, asymmetric Type I bands should be used only for the training dataset having dispersed x‐values, a relatively large confidence level 1α, and a small sample size n. Therefore, asymmetric Type II bands, like UVa, are recommended in general.

FIGURE 2.

FIGURE 2

The ratios r=Area(RT;TBEa)Area(RT;UVa) of Area(RT) for TBEa relative to UVa, with ϕ(0,π), n=10, γ=0.75,0.95 and 1α=0.90,0.99. (a) γ=0.75, (b) γ=0.95.

4. Illustrative Example

In order to illustrate how to determine the shelf‐life of a drug based on the method of SCBs for a percentile line, we revisit the real data example on drug stability from Ruberg and Hsu [17]. We also provide a visual demonstration of the SCBs and their corresponding constrained regions RT. For the data from the first batch of Experiment One in Ruberg and Hsu [17], the fitted model is ŷ=98.2441.515(xx) with x=i=1nxi/n=1.482, σ^=0.137 and n=9.

For given y, X, (a,b)=(0,2), γ=0.05 and 1α=0.95, Table 3 shows the r‐ratios of areas of regions RT relative to the UVa band, including (i) the symmetric SCBs (SB, TBU, TBE, V, TT, UV) and (ii) the asymmetric SCBs (SBa, TBUa, TBEa, Va, TTa, UVa). It is clear that the Area(RT)‐values for asymmetric SCBs are substantially smaller than those for symmetric SCBs under the MACS criterion. Based on the numerical results, we can conclude that the UVa band is the best under the MACS criterion in this example.

TABLE 3.

Ratios r of Area(RT) relative to the UVa band for the drug stability data.

Bands Ratio Bands Ratio Bands Ratio Bands Ratio
SBUVa
1.579
VUVa
1.425
SBaUVa
1.089
VaUVa
1.002
TBUUVa
1.473
TTUVa
1.334
TBUaUVa
1.089
TTaUVa
1.000
TBEUVa
1.235
UVUVa
1.335
TBEaUVa
1.091
UVaUVa
1

Note: SB, TBU, TBE, V, TT and UV are the symmetric SCBs. SBa, TBUa, TBEa, Va, TTa and UVa are the asymmetric SCBs.

In order to visually demonstrate the disparity in the areas of constrained regions RT, we consider the Area(RT) for TBE, UV, TBEa, and UVa, since TBE and UV represent the best options among Type I and Type II bands, respectively. Figure 3a gives the areas of RT for TBE, UV, TBEa, and UVa using a solid line, dash line, dash‐dotted line, and dotted line, respectively. It is shown in Figure 3a that Area(RT) for UVa is the smallest.

FIGURE 3.

FIGURE 3

(a) The areas of RT for TBE, UV, TBEa, and UVa in the coordinates (t1, t2); (b) The 95% asymmetric band UVa for the 5th percentile.

In order to illustrate the estimation of shelf‐life based on SCBs for percentiles in linear regression, the UVa band is used, as it has been identified as the optimal choice from Table 3 and Figure 3a. In Figure 3b, the estimated percentile line xTβ^+zγσ^/ξ1 with ξ1=2νΓ(ν+12)Γ(ν2)=0.965 is shown by the solid line, and the UVa band is given by the dotted lines. The critical constants (c1,c2) for UVa are (3.230, 2.016). For the given threshold h=98, which is given by the dash‐dotted line, one can infer from the UVa band that, the percentile line xTβ+zγσ is above h before the time point x=1.327 with 1α=95% confidence level, and so at least 1γ=95% proportion of all the dosage units have drug content above h by this time point. But beyond the time point x=1.591, the percentile line xTβ+zγσ is below h with 95% confidence level, and so less than 1γ=95% proportion of all the dosage units have drug content above h. It should be noted that the true shelf‐life Xγ at which β0+β1(Xγx)+zγσ=h can be anywhere in the interval Xγ(1.327,1.591).

In general, according to the area of RT in Figure 3a and the numerical results in Table 3, the asymmetric Type II bands (Va, UVa and TTa) have smaller volume of confidence sets for unknown parameter θ=(β0,β1,σ)T and should be used under the MACS criterion.

5. Conclusion

Drug stability studies are an important part of any pharmaceutical drug development programme. The interval estimation of true shelf‐life based on the mean drug content of a selected dosage unit only guarantees that half of all the dosage units have the drug content no less than the pre‐specified level h by the estimated shelf‐life. This may not be satisfactory from the patients' point of view unless the therapeutic effect of a dosage unit with drug content below h is well understood.

In this paper, the true shelf‐life is set as the time point at which no more than 100γ% of all the dosage units will have the drug content less than a pre‐specified lowest acceptable limit h, where γ is a pre‐specified number close to 0. Constructing the exact (1α)‐level SCBs for the 100γth percentile line in linear regression is the appropriate way for estimating the shelf‐life in this situation.

In this paper, we propose the MACS criterion, allowing for the comparison of different types of SCBs for percentile lines based on the area of the region for our new pivotal quantity T. In addition, our newly proposed method of computing the critical constants of SCBs for percentile lines is more efficient than the methods previously available in the statistical literature. Moreover, the optimal SCB under the MACS can be used to construct the interval estimation of shelf‐life in drug stability studies.

Based on our numerical results, we observe that the optimal MACS asymmetric bands are inherently superior to the corresponding symmetric bands under the MACS criterion, as expected, making them the preferred choice. In most cases, the asymmetric Type II bands perform better than the asymmetric Type I bands. Therefore, asymmetric Type II bands, like UVa, are recommended.

Although this paper only focuses on the simple linear regression model, the proposed method can be extended to multiple regression and polynomial regression. For multiple regression involving more than one covariate, the MACS‐based method can be applied, and the polar coordinates of K can be directly used to calculate the critical constants. The computational cost remains comparable to that of simple linear regression, taking approximately 10 s for symmetric SCBs and about 200 s for asymmetric SCBs. The computation time does not increase with the number of covariates. For polynomial regression, the critical constants cannot be determined directly using the polar coordinates of the pivotal quantity K. In such cases, a simulation‐based approach can be employed instead. The computation time increases due to the optimization involved. With 1 000 000 simulations, the computation time is approximately 3×103 s for symmetric SCBs and over 2×104 s for asymmetric SCBs. These times can be substantially reduced through parallel computing with an increased number of cores.

Furthermore, the MACS criterion can be used to select optimal simultaneous tolerance intervals for linear regression, which is currently under research and will be reported separately in the future.

Conflicts of Interest

The authors declare no conflicts of interest.

Supporting information

Data S1. The Supporting Information provides the computational costs of our newly proposed method and the previous simulation‐based method, as well as the additional numerical results in Section 3.

SIM-44-0-s001.pdf (130.8KB, pdf)

Appendix A. Derivation of the confidence set Cθ

To derive the confidence set Cθ for unknown parameters θ=(β0,β1,σ)T according to the region RK, we need identify the relation between θ and the pivotal quantity K. Recall a=zγnξ11+nzγ2ξ2,0T, b=(β^0,β^1,0)T, M=11+nzγ2ξ2001 and U=1σ^n0zγn0Sxx0 as defined in (7), we have

K=K1K2=N1zγnU1+nzγ2ξ2+zγnξ11+nzγ2ξ2N2/U=N1zγnU1+nzγ2ξ2N2/U+zγnξ11+nzγ2ξ20=1σ^n(β0^β0)σzγn1+nzγ2ξ2Sxx(β1^β1)+a=1σ^11+nzγ2ξ2001n0zγn0Sxx0β0^β0β1^β1σ+a=MU(bθ)+a.

Hence, the confidence set Cθ can be expressed as

Cθ=θ:K=MU(bθ)+aRK=θ:MU(bθ)+aRK.

Appendix B. Derivation of Area(RK)

Set cmin=min(c1,c2) and cmax=max(c1,c2), where c1 and c2 are defined in (4). The Area(RK) in (8) can be calculated for the following situations.

  1. When ϕ<π/2, Area(RK)=(cmin/cosϕ+cmax)2/tanϕcmin2tanϕ+ϕ(c12+c22)/2.

  2. When ϕ=π/2, Area(RK)=2c1c2+ϕ(c12+c22)/2.

  3. When ϕ>π/2,
    • (1)
      if cmin/cos(πϕ)>cmax, Area(RK)=cmin2tan(πϕ)(cmin/cos(πϕ)cmax)2/tan(πϕ)+ϕ(c12+c22)/2;
    • (2)
      if cmin/cos(πϕ)cmax, Area(RK)=cmincmax2cmin2+cmin2ϕ/2+cmax2(2πϕ2arccos(cmin/cmax))/2.

Appendix C. Joint density function of (K1,K2)

Since N1N(0,1), N2N(0,1) and Uχν2/ν with ν=n2 in (4) are independent, the joint density function of (N1,N2,U) is

f(n1,n2,u)=νν/22ν/2πΓ(ν/2)uν1exp(12(n12+n22+νu2)). (A1)

Now, consider the pdf for K=(K1,K2)T with

K1=q1N1q3U+q2andK2=N2/U

where q1=11+nzγ2ξ2, q2=zγnξ11+nzγ2ξ2 and q3=zγn. Define the random variable K3=U, so that N1, N2 and U can be solved in terms of K1, K2 and K3 as

N1=K3K1q2q1+q3,N2=K2K3andU=K3. (A2)

This gives the following Jacobian matrix and determinant

J=N1K1N1K2N1K3N2K1N3K2N3K3UK1UK2UK3=K3q10K1q2q10K3K2001|J|=K32/q1. (A3)

It follows immediately that the joint density of K1, K2 and K3 is given by

fK1,K2,K3(k1,k2,k3)=fN,U(n1,n2,u)|J|.

Combining ((A1), (A2), (A3)) gives

fK1,K2,K3(k1,k2,k3)=νν/2q12ν/2πΓ(ν/2)k3ν+1×exp12k1q2q12+k22+νk32+2q3(k1q2)q1k3+q32.

Integrating out k3 gives the (marginal) density of K1 and K2

fK1,K2(k1,k2)=exp(q32/2)νν/2q12ν/2πΓ(ν/2)0k3ν+1×exp12k1q2q12+k22+νk32+2q3(k1q2)q1k3dk3.

Appendix D. Proof of Theorem 2

Before we prove the Theorem 2, we need the following two lemmas.

Lemma 1

Let K be the pivotal quantity in ( 5 ) and RK be the region in ( 6 ). For given critical constants c1 and c2, the confidence level of the SCB in ( 3 ) is

PxTβ^+zγσ^/ξ1c1σ^xT(XTX)1x+(zγ)2ξ2xTβ+zγσxTβ^+zγσ^/ξ1+c2σ^xT(XTX)1x+(zγ)2ξ2for allx(a,b)=Pc2wTKwc1for allx(a,b)=PKRK.

In order to calculate the probability P{KRK}, all three different situations are considered below. The angles ϕ1 and ϕ2 are defined in Figure 1a,b, while the angles ζ1, ζ2, ϕ1, ϕ1, ϕ2 and ϕ2 are defined in Figure 1d.

  1. When ϕ<π2, we have ζ1=arctanc2cosϕ+c1tanπ2ϕ/c1, ζ2=πζ1ϕ, ϕ1=ϕ1=ϕ1 and ϕ2=ϕ2=ϕ2.

  2. When ϕ=π2, we have ζ1=arctanc2c1, ζ2=πζ1ϕ, ϕ1=ϕ1=ϕ1 and ϕ2=ϕ2=ϕ2.

  3. When ϕ>π2,
    • (1)
      if cmin/cos(πϕ)>cmax, we have ζ1=arctanc2cos(πϕ)c1tanϕπ2/c1, ζ2=πζ1ϕ, ϕ1=ϕ1=ϕ1 and ϕ2=ϕ2=ϕ2;
    • (2)
      if cmin/cos(πϕ)cmax,
      • (i)
        suppose c1c2, ζ1=arccosc1c2, ζ2=0, ϕ1=ϕ1, ϕ2=ϕ2, ϕ1=πϕ2ζ1, and ϕ2=πϕ1ζ1;
      • (ii)
        suppose c1>c2, ζ1=0, ζ2=arccosc2c1, ϕ1=ϕ1, ϕ2=ϕ2, ϕ1=πϕ2ζ1, and ϕ2=πϕ1ζ1.

The next lemma provides the derivation of RK using a method involving partitions and polar coordinates (R,δ).

Lemma 2

For any SCB in ( 3 ), the corresponding RK in Figure  1 d is partitioned as:

RK=i=14RK;MiRK;Oi

where

RK;M1={K:δ[ϕ1,ϕ1+ζ1),0cosϕ1,sinϕ1Kc1}=(R,δ):δ[ϕ1,ϕ1+ζ1),Rc1cosδϕ1RK;M2={K:δ[ϕ1+ζ1,πϕ2),0cosπϕ2,sinπϕ2Kc2}=(R,δ):δ[ϕ1+ζ1,πϕ2),Rc2cosδπ+ϕ2RK;M3={K:δ[π+ϕ1,π+ϕ1+ζ2),0cosπ+ϕ1,sinπ+ϕ1Kc2}=(R,δ):δ[π+ϕ1,π+ϕ1+ζ2),Rc2cosδπϕ1RK;M4={K:δ[π+ϕ1+ζ2,2πϕ2),0cos2πϕ2,sin2πϕ2Kc1}=(R,δ):δ[π+ϕ1+ζ2,2πϕ2),Rc1cosδ2π+ϕ2RK;O1={K:δ[0,ϕ1),||K||c1}={(R,δ):δ[0,ϕ1),Rc1}RK;O2={K:δ[πϕ2,π),||K||c2}={(R,δ):δ[πϕ2,π),Rc2}RK;O3={K:δ[π,π+ϕ1),||K||c2}={(R,δ):δ[π,π+ϕ1),Rc2}RK;O4={K:δ[2πϕ2,2π),||K||c1}={(R,δ):δ[2πϕ2,2π),Rc1}.

From Lemmas 1 and 2, we can derive Theorem 2.

Following Lemmas 1 and 2, the confidence level of the SCB in (3) given c1 and c2 is

PxTβ^+zγσ^ξ1c1σ^xT(XTX)1x+(zγ)2ξ2xTβ+zγσxTβ^+zγσ^ξ1+c2σ^xT(XTX)1x+(zγ)2ξ2forallx(a,b)=Pc2wTKwc1for allx(a,b)=PKRK=PKi=14RK;MiRK;Oi=P(R,δ)i=14RK;MiRK;Oi=i=14P(R,δ)RK;Mi+P(R,δ)RK;Oi=i=14(R,δ)RK;MifR,δ(r,δ)drdδ+(R,δ)RK;OifR,δ(r,δ)drdδ. (A4)

The Equation (A4) is based on the independence of regions RK;Mi and RK;Oi, i=1,,4.

Wang L., Han Y., Liu W., and Bretz F., “Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf‐Life Estimation,” Statistics in Medicine 44, no. 20‐22 (2025): e70184, 10.1002/sim.70184.

Funding: The authors received no specific funding for this work.

Data Availability Statement

The R code for the simulation studies and the real data example is available at https://github.com/Lingjiao‐WANG/MACS; the results of these analyses are presented in the paper and the Supporting Information.

References

  • 1. International Conference on Harmonization , “Topic Q1A (R2): Stability Testing of New Drug Substances and Products,” (2003), https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
  • 2. International Conference on Harmonization , “Topic Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances,” (1999), https://database.ich.org/sites/default/files/Q6AGuideline.pdf. [PubMed]
  • 3. Kiermeier A., Jarrett R. G., and Verbyla A. P., “A New Approach to Estimating Shelf‐Life,” Pharmaceutical Statistics 3, no. 1 (2004): 3–11. [Google Scholar]
  • 4. Quinlan M., Stroup W., Schwenke J., and Christopher D., “Evaluating the Performance of the ICH Guidelines for Shelf Life Estimation,” Journal of Biopharmaceutical Statistics 23, no. 4 (2013): 881–896. [DOI] [PubMed] [Google Scholar]
  • 5. Liu W., Hsu J. C., Bretz F., Hayter A. J., and Han Y., “Shelf‐Life and Its Estimation in Drug Stability Studies,” Journal of Applied Statistics 41, no. 9 (2014): 1989–2000. [Google Scholar]
  • 6. Ruberg S. J. and Stegeman J. W., “Pooling Data for Stability Studies: Testing the Equality of Batch Degradation Slopes,” Biometrics 47, no. 3 (1991): 1059–1069. [PubMed] [Google Scholar]
  • 7. Steinhorst R. K. and Bowden D. C., “Discrimination and Confidence Bands on Percentiles,” Journal of the American Statistical Association 66, no. 336 (1971): 851–854. [Google Scholar]
  • 8. Turner D. L. and Bowden D. C., “Simultaneous Confidence Bands for Percentile Lines in the General Linear Model,” Journal of the American Statistical Association 72, no. 360a (1977): 886–889. [Google Scholar]
  • 9. Turner D. L. and Bowden D. C., “Sharp Confidence Bands for Percentile Lines and Tolerance Bands for the Simple Linear Model,” Journal of the American Statistical Association 74, no. 368 (1979): 885–888. [Google Scholar]
  • 10. Thomas D. L. and Thomas D. R., “Confidence Bands for Percentiles in the Linear Regression Model,” Journal of the American Statistical Association 81, no. 395 (1986): 705–708. [Google Scholar]
  • 11. Han Y., Liu W., Bretz F., and Wan F., “Simultaneous Confidence Bands for a Percentile Line in Linear Regression,” Computational Statistics and Data Analysis 81 (2015): 1–9. [Google Scholar]
  • 12. Gafarian A. V., “Confidence Bands in Straight Line Regression,” Journal of the American Statistical Association 59, no. 305 (1964): 182–213. [Google Scholar]
  • 13. Liu W., Ah‐kine P., and Zhou S., “Simultaneous Confidence Bands for Linear Regression With Covariates Constrained in Intervals,” Scandinavian Journal of Statistics 39, no. 3 (2012): 543–553. [Google Scholar]
  • 14. Liu W. and Hayter A. J., “Minimum Area Confidence Set Optimality for Confidence Bands in Simple Linear Regression,” Journal of the American Statistical Association 102, no. 477 (2007): 181–190. [Google Scholar]
  • 15. Liu W., Lin S., and Piegorsch W. W., “Construction of Exact Simultaneous Confidence Bands for a Simple Linear Regression Model,” International Statistical Review 76, no. 1 (2008): 39–57. [Google Scholar]
  • 16. Liu W. and Ah‐kine P., “Optimal Simultaneous Confidence Bands in Simple Linear Regression,” Journal of Statistical Planning and Inference 140, no. 5 (2010): 1225–1235. [Google Scholar]
  • 17. Ruberg S. J. and Hsu J. C., “Multiple Comparison Procedures for Pooling Batches in Stability Studies,” Technometrics 34, no. 4 (1992): 465–472. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data S1. The Supporting Information provides the computational costs of our newly proposed method and the previous simulation‐based method, as well as the additional numerical results in Section 3.

SIM-44-0-s001.pdf (130.8KB, pdf)

Data Availability Statement

The R code for the simulation studies and the real data example is available at https://github.com/Lingjiao‐WANG/MACS; the results of these analyses are presented in the paper and the Supporting Information.


Articles from Statistics in Medicine are provided here courtesy of Wiley

RESOURCES